CD1b-restricted GEM T cell responses are modulated by Mycobacterium tuberculosis mycolic acid meromycolate chains
- aAcademic Unit of Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, United Kingdom;
- bPublic Health England, National Infections Service, Porton Down, Salisbury SP4 0JQ, United Kingdom;
- cSchool of Chemistry, University of Southampton, Southampton SO17 1BJ, United Kingdom;
- dSchool of Chemistry, Bangor University, Bangor, Gwynedd LL57 2UW, United Kingdom;
- eCellular Therapeutics Ltd, Manchester M13 9XX, United Kingdom;
- fSchool of Biological Sciences, University of Southampton, Southampton SO17 1BJ, United Kingdom;
- gInstitute for Life Sciences, University of Southampton, Southampton SO17 1BJ, United Kingdom;
- hHistochemistry Unit, University of Southampton, Southampton SO16 6YD, United Kingdom;
- iImmunocore Ltd., Abingdon, Oxon OX14 4RY, United Kingdom;
- jNIHR Southampton Biomedical Research Centre, Southampton SO17 1BJ, United Kingdom;
- kGlobal Health Research Institute, University of Southampton, Southampton SO17 1BJ, United Kingdom;
- lDepartment of Paediatrics, Faculty of Medicine, University of Melbourne, 3052 Parkville, Australia;
- mDepartment of Paediatric Infectious Diseases & Immunology, Evelina London Children’s Hospital, Guy’s and St. Thomas’ NHS Foundation Trust, London SE1 7EH, United Kingdom;
- nCancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, United Kingdom;
- oF. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland
See allHide authors and affiliations
Edited by Philippa Marrack, National Jewish Health, Denver, CO, and approved October 23, 2017 (received for review June 9, 2017)

Significance
Tuberculosis is a major global pandemic responsible for more deaths than any other infectious disease, yet no effective vaccine exists. Here, we demonstrate CD1b expression within human tuberculous granulomas, supporting a role for CD1b lipid antigen presentation in host immunity to infection. CD1b presents mycolates, the dominant Mycobacterium tuberculosis (Mtb) cell wall lipid class and key virulence factors, to αβ T cells. We reveal that mycolate tail moieties, distal to the head group, are antigenic determinants for the conserved human germline-encoded mycolyl lipid-reactive (GEM) T cell receptors (TCRs). Computational simulations suggest a putative mechanism whereby lipid-ligand dynamics within CD1b regulate GEM-TCR activity. This work provides insights for the development of major histocompatibility complex (MHC)-independent Mtb lipid vaccines, including those that target GEM T cells.
Abstract
Tuberculosis (TB), caused by Mycobacterium tuberculosis, remains a major human pandemic. Germline-encoded mycolyl lipid-reactive (GEM) T cells are donor-unrestricted and recognize CD1b-presented mycobacterial mycolates. However, the molecular requirements governing mycolate antigenicity for the GEM T cell receptor (TCR) remain poorly understood. Here, we demonstrate CD1b expression in TB granulomas and reveal a central role for meromycolate chains in influencing GEM-TCR activity. Meromycolate fine structure influences T cell responses in TB-exposed individuals, and meromycolate alterations modulate functional responses by GEM-TCRs. Computational simulations suggest that meromycolate chain dynamics regulate mycolate head group movement, thereby modulating GEM-TCR activity. Our findings have significant implications for the design of future vaccines that target GEM T cells.
Footnotes
↵1Present address: Department of Medicine, New York University School of Medicine, New York, NY 10016.
- ↵2To whom correspondence should be addressed. Email: s.mansour{at}soton.ac.uk.
Author contributions: A.C., S.G., and S.M. designed research; A.C., A.S.T., C.C.-A., L.T., A.W., J.R.A.D., N.M.L., T.E., C.-K.S., J.W.E., P.E., and S.M. performed research; J.R.A.D., J.S.B., S.W., N.M.L., M.T., B.M., M.S.B., and P.E. contributed new reagents/analytic tools; A.C., C.C.-A., L.T., A.W., J.S.B., I.T., S.W., M.T., B.M., S.S., T.E., C.-K.S., J.W.E., M.S.B., S.G., P.E., and S.M. analyzed data; and A.C. and S.M. wrote the paper.
The authors declare no conflict of interest.
This article is a PNAS Direct Submission.
See Commentary on page 13312.
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.1073/pnas.1708252114/-/DCSupplemental.
Published under the PNAS license.
Citation Manager Formats
Article Classifications
- Biological Sciences
- Immunology and Inflammation
- Physical Sciences
- Chemistry
See related content: